AMRX AMNEAL PHARMACEUTICALS INC Earnings Reports 8-K Filing 2024 - Earnings Reports Amneal Pharmaceuticals, Inc. issued a press release announcing its second quarter results and the FDA approval of CREXONT for Parkinson's disease treatment.Get access to all SEC 8-K filings of the AMNEAL PHARMACEUTICALS INC